Breast Cancer Liquid Biopsy Market to Reach USD 2.40 Billion by 2032 at 19.86% CAGR
Key Highlights Global market valued at USD 675.59 million in 2025. Expected to reach USD 2,401.07 million by 2032. Forecast CAGR stands at 19.86% during 2026–2032. Precision oncology is accelerating demand for blood-based molecular diagnostics. Hospitals increasingly adopt liquid biopsy … Read more